Sensyne Algorithm For COVID-19 Risk Prediction Gets UK Regulatory Approval

Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.

Sensyne Health obtained UK regulatory approval for the SYNE-COV machine learning algorithm, developed in collaboration with the Chelsea and Westminster Hospitals NHS Foundation Trust, the company announced on 1 March.

SYNE-COV is the first Sensyne clinical AI algorithm developed for Sensyne’s SENSE clinical AI platform to achieve regulatory approval. It...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight